Annals of Hematology

, Volume 86, Issue 12, pp 865–870 | Cite as

The clinical significance of non-malignant neutropenia in hospitalized children

  • Vasiliki VlachaEmail author
  • Gavriella Feketea
Original Article


Neutropenia in non-cancer patients is often discovered in the course of an evaluation for acute infection, and it is usually secondary to the infection itself rather than a predisposing factor of the infection. Although it is not a common finding in hospitalized pediatric patients, it causes a great concern to the treating physicians. The aim of this study was to determine the incidence, the etiology, and the clinical significance of neutropenia in previously healthy children admitted in a general pediatric ward. One thousand five hundred and forty-eight patients admitted during a period of 18 months were included in the study. The clinical characteristics, the complete blood count, and the sedimentation rate were recorded. A total of 143 (9.2%) pediatric patients were identified as neutropenic, with mean absolute neutrophilic count of 0.960 × 109/l (SD 0.341 × 109/l) and ranged from 0.200 to 1.499 × 109/l. The neutropenic patients had lower hemoglobin of 11.2 mg/dl and ranged from 6.2 to 17.2 mg/dl compared to hemoglobin of 11.5 mg/dl, which ranged from 5.2 to 18.0 mg/dl of the individuals with normal neutrophils, p < 0.0001 and lower mean platelet count of 294 × 109/l, which ranged from 122 to 929 × 109/l compared to platelet count of 381 × 109/l, which ranged from 90–165 × 109/l of the individuals without neutropenia, p < 0.001. Additionally, those patients were significantly younger than the non-neutropenic ones. Infection was the most common cause of neutropenia, although none of them developed septicemia. The neutrophil count normalized in most of the patients before discharge. However, 12 (8.3%) of neutropenic patients were discharged with persistent findings. Two of those were finally diagnosed with autoimmune neutropenia. In conclusion, the acquired neutropenia in hospitalized patients without malignancy is mild to moderate. It has no influence on the clinical outcome. Importantly, it has short duration, and it is usually resolved before patient’s discharge.


Neutropenia Non-malignant Child Hospitalization 


  1. 1.
    Sievers EL, Dale DC (1996) Non-malignant neutropenia. Blood Rev 10:95–100PubMedCrossRefGoogle Scholar
  2. 2.
    Vesta KS, Medina PJ (2003) Valproic acid-induced neutropenia. Ann Pharmacother 37(6):819–821PubMedCrossRefGoogle Scholar
  3. 3.
    Lindblad R, Rodjer S (1991) A case of severe pancytopenia caused by ibuprofen. J Intern Med 229(3):281–283PubMedCrossRefGoogle Scholar
  4. 4.
    Klein I, Levey GS (1984) Unusual manifestations of hypothyroidism. Arch Intern Med 144:123–128PubMedCrossRefGoogle Scholar
  5. 5.
    Sloand E (2005) Hematologic complications of HIV infection. AIDS Rev 7(4):187–196PubMedGoogle Scholar
  6. 6.
    Istomin V, Sade E, Grossman Z, Rudich H, Zudich H, Sofer O, Hassin D (2004) Agranulocytosis associated with parvovirus B19 infection in otherwise healthy patients. Eur J Intern Med 15(8):531–533PubMedCrossRefGoogle Scholar
  7. 7.
    Lehman HW, von Landenberg P, Modrow S (2003) Parvovirus B19 infection and autoimmune disease. Autoimmun Rev 2(4):218–223CrossRefGoogle Scholar
  8. 8.
    Imashuku S, Hibi S, Kuriyama K, Tabata Y, Hashida T, Iwai A, Kato M, Yamashita N, Oda M, Uchida M, Kinugawa N, Sawada M, Konno M (2000) Management of severe neutropenia with cyclosporin during initial treatment of Epstein–Barr virus-related hemophagocytic lymphohistiocytosis. Leuk Lymphoma 36(3–4):339–346PubMedCrossRefGoogle Scholar
  9. 9.
    Singh KJ, Ahluwalia G, Sharma SK, Saxena R, Chaudhary VP, Anant M (2001) Significance of haematological manifestations in patients with tuberculosis. J Assoc Phys India 49:788, 790–794Google Scholar
  10. 10.
    Nord JA, Kislak JW (2002) Profound neutropenia and atypical lymphocytosis in a traveller to Ghana. Int J Infect Dis 6(1):87–88PubMedCrossRefGoogle Scholar
  11. 11.
    Chung BH, Chan GC, Lee TL, Kwok JS, Chiang AK, Ho HK, Ha SY, Lau YL (2004) Chronic benign neutropenia among Chinese children. 1. Hong Kong Med J 10(4):231–236PubMedGoogle Scholar
  12. 12.
    Bux J, Behrens G, Jaeger G, Welte K (1998) Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 1; 91(1):181–186PubMedGoogle Scholar
  13. 13.
    Smith MA, Smith JG (2002) Clinical experience with the use of rhG-CSF in secondary autoimmune neutropenia. Clin Lab Haematol 24(2):93–97PubMedCrossRefGoogle Scholar
  14. 14.
    Bruin M, Dassen A, Pajkrt D, Buddelmeyer L, Kuijpers T, de Haas M (2005) Primary autoimmune neutropenia in children: a study of neutrophil antibodies and clinical course. Vox Sang 88(1):52–59PubMedCrossRefGoogle Scholar
  15. 15.
    Capsoni F, Sarzi-Puttini P, Zanella A (2005) Primary and secondary autoimmune neutropenia. Arthritis Res Ther 7(5):208–214PubMedCrossRefGoogle Scholar
  16. 16.
    Palmblad J, Papadaki HA, Eliopoulos G (2001) Acute and chronic neutropenias. What is new? J Intern Med 250(6):476–491PubMedCrossRefGoogle Scholar
  17. 17.
    Dale DC, Liles C (1998) How many neutrophils are enough? Lancet 351(9118):1752–1753PubMedCrossRefGoogle Scholar
  18. 18.
    Asmar BI, Maqbool S, Dajani AS (1981) Hematologic abnormalities after oral trimethoprim–sulfamethoxazole therapy in children. Am J Dis Child 135(12):1100–1103PubMedGoogle Scholar
  19. 19.
    Tantawichien T, Tungsanga K, Swasdikul D (1994) Reversible severe neutropenia after ceftriaxone. Scand J Infect Dis 26(1):109–110PubMedGoogle Scholar
  20. 20.
    Kumar K, Kumar A (1981) Reversible neutropenia associated with ampicillin therapy in pediatric patients. Drug Intell Clin Pharm 15(10):802–806PubMedGoogle Scholar
  21. 21.
    Lyall EGH, Lukas GF, Eden OB (1992) Autoimmune neutropenia of infancy. J Clin Pathol 45:431PubMedCrossRefGoogle Scholar
  22. 22.
    Malcolm L, Bridgden MD (1999) Clinical utility of the erythrocyte sedimentation rate. Am Fam Phys 60(5):1443–1454Google Scholar
  23. 23.
    Papadaki HA, Charoulakis NZ, Eliopoulos DG, Psyllaki M, Eliopoulos GD (2001) Patients with non-immune chronic idiopathic neutropenia syndrome have increased splenic volume on ultrasonography. Clin Lab Haematol 23(2):111–117PubMedCrossRefGoogle Scholar
  24. 24.
    Papadaki HA, Pontikoglou C, Eliopoulos DG, Pyrovolaki K, Spyridaki R, Eliopoulos GD (2006) Helicobacter pylori infection is probably the cause of chronic idiopathic neutropenia (CIN)-associated splenomegaly. Am J Hematol 81(2):142–144PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  1. 1.Division of Pediatric Hematology–Oncology, Department of PediatricsUniversity of Patras School of Medicine, General University HospitalPatrasGreece
  2. 2.General Hospital of AmaliadaAmaliadaGreece

Personalised recommendations